Unknown EARLY_PHASE1 INTERVENTIONAL 2-arm NCT05427513

Efficacy of Tranexamic Acid in Preventing Post Operative Blood Loss in Bone Sarcoma Patient

Efficacy of Tranexamic Acid in Preventing Post Operative Blood Loss and Associated Complications in Bone Sarcoma Patients Treated With Limb Salvage Surgery: A Randomized Controlled Trial

Sponsor: Shaukat Khanum Memorial Cancer Hospital & Research Centre

Conditions Blood Loss, Surgical

Interventions Tranexamic acid injection normal saline

Updated 5 times since 2022 Last updated: Mar 27, 2023 Started: Apr 6, 2022 Primary completion: Dec 31, 2023 Completion: Feb 28, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Blood Loss, Surgical and is currently ongoing. Shaukat Khanum Memorial Cancer Hospital & Research Centre leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Apr 2025 — Present [monthly]

Unknown EARLY_PHASE1

Status: Recruiting → Unknown
Sep 2024 — Apr 2025 [monthly]

Recruiting EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Recruiting EARLY_PHASE1
Apr 2023 — Jul 2024 [monthly]

Recruiting EARLY_PHASE1
Jul 2022 — Apr 2023 [monthly]

Recruiting EARLY_PHASE1

First recorded

Apr 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shaukat Khanum Memorial Cancer Hospital & Research Centre

Data source: Shaukat Khanum Memorial Cancer Hospital & Research Centre

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lahore, Pakistan